相关实验视频

Updated: Jun 18, 2025

Tumor Engraftment in a Xenograft Mouse Model of Human Mantle Cell Lymphoma
10:52

Tumor Engraftment in a Xenograft Mouse Model of Human Mantle Cell Lymphoma

Published on: March 30, 2018

11.1K

布拉斯托菌地幔细胞淋巴瘤的临床和病理特征:一个单一机构的经验

Vidya Monappa1, Swathi Prabhu1, Ranjini Kudva1

  • 1Department of Pathology, Kasturba Medical College, Manipal, Manipal Academy of Higher Education, Manipal, Karnataka, 576104, India.

F1000Research
|August 5, 2024
PubMed

Insights

布拉斯托性地幔细胞淋巴瘤 (B-MCL) 是一种攻击性的癌症. 这项研究发现B-MCL的生存结果很差,突出了需要新的治疗方法.

科学领域:

  • 血液学 血液学 血液学
  • 在瘤学瘤学.
  • 病理学 病理学 病理学

背景情况:

  • 布拉斯托性地幔细胞淋巴瘤 (B-MCL) 是一种罕见且激进的非霍奇金淋巴瘤形式.
  • 它的诊断具有挑战,因为它具有状体形态,高增殖率和可变的免疫组织化学 (IHC).

研究的目的:

  • 分析B-MCL.的临床,组织病理和生存特征.
  • 为了比较B-MCL结果与经典的地幔细胞淋巴瘤 (MCL).

主要方法:

  • 对2012-2022年间诊断的12例B-MCL病例进行了回顾性队列研究.
  • 与12个经典的MCL病例进行比较.
  • 临床表现分析,IHC,Ki-67指数,p53表达和整体生存时间 (OS).

主要成果:

  • B-MCL病例的平均生存期为2年,而经典的MCL则为8年.
  • 在B-MCL.中观察到高Ki-67指数 (58.09%) 和p53过度表达 (66.6%).
  • 共有的特征包括从MCL转变,新出现,外干涉 (50%) 和骨髓干涉 (81.8%).

结论:

  • B-MCL是一种侵略性淋巴瘤,生存率明显低于经典的MCL.
  • 导致侵略性的因素需要探索新的治疗策略.
抽象的

No abstract available in PubMed .

关键词:
地膜细胞淋巴瘤是什么布拉斯托伊德 (Blastoid) 是一种类型的环素 D1 D1 的时间.淋巴瘤淋巴瘤是什么

更多相关视频

Isolating Human Peripheral Blood Mononuclear Cells and CD4+ T cells from Sézary Syndrome Patients for Transcriptomic Profiling09:08

Isolating Human Peripheral Blood Mononuclear Cells and CD4+ T cells from Sézary Syndrome Patients for Transcriptomic Profiling

Published on: October 14, 2021

5.4K
Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up09:01

Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up

Published on: March 26, 2018

14.0K

相关概念视频

Disorders of Leukocytes01:27

Disorders of Leukocytes

Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
923
Cells of the Adaptive Immune Response01:23

Cells of the Adaptive Immune Response

The T and B lymphocytes of the adaptive immune system develop from common lymphoid progenitor cells in the bone marrow. These progenitors give rise to precursors that eventually develop into both T and B lymphocytes. As these precursors mature, they gain the ability to detect and respond to foreign antigens in the body, a process known as immunocompetence. Additionally, these precursors acquire self-tolerance, a process that ensures they do not react to self-antigens. This intricate system...
972